Article Information
History
- February 23, 2021.
Article Versions
- Version 1 (October 13, 2020 - 09:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Antoine Salzmann1,*,
- Sarah-Naomi James1,
- Dylan M. Williams1,2,
- Marcus Richards1,
- Dorina Cadar3,
- Jonathan M. Schott4,
- William Coath4,
- Carole H. Sudre4,5,
- Nishi Chaturvedi1 and
- Victoria Garfield1
- 1MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK
- 2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- 3Department of Behavioural Science and Health, University College London, London, UK
- 4Department of Neurodegenerative Disease, The Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
- 5School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK
- ↵*CORRESPONDING AUTHOR:
Antoine Salzmann, MRC Unit for Lifelong Health and Ageing at UCL, University College London, 5th floor | 1-19 Torrington Place | London | WC1E 7HB | London, United Kingdom, Phone: +44 (0) 2076705723, Email: antoine.salzmann.14{at}ucl.ac.uk
Posted February 23, 2021.
Investigating the relationship between IGF-I, -II and IGFBP-3 concentrations and later-life cognition and brain volume
